Why Are Zogenix's Shares Gaining Today?
The FDA has granted Priority Review to Zogenix Inc's (NASDAQ:ZGNX) supplemental marketing application seeking approval for Fintepla (fenfluramine) in Lennox-Gastaut syndrome (LGS)…
Author
